Chromatin maintenance in cancer progression

癌症进展中的染色质维持

基本信息

  • 批准号:
    9150499
  • 负责人:
  • 金额:
    $ 45.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-30 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Mutations in chromatin regulatory proteins have recently been identified in a wide range of human cancers. Although these mutations are associated with disease progression, how they contribute to tumorigenesis remains unknown. We propose to investigate SETD2, a non-redundant histone methyltransferase that preferentially places a trimethylation mark on Histone H3 on lysine 36 in actively transcribed gene bodies. This gene is mutated in approximately 15% of renal cell carcinomas, and is being identified in a growing list of tumors. By examining chromatin organization in primary human tumors, we observed that SETD2 mutation and loss of its histone modification were associated with changes in nucleosome accessibility and widespread alteration in RNA processing. We hypothesize that histone mark dysregulation through SETD2 loss is an important component of tumorigenesis. We propose a highly collaborative project that employs biochemical, genetic and genomic approaches to comprehensively explore the effect of SETD2 mutation on chromatin and transcription, in an effort to unravel the mechanisms by which SETD2 loss leads to the promotion of cancer. To this end, we have generated a unique set of cell-based model systems which uses comparative genomic studies between human and yeast cells. We have additionally established novel domain-specific activities of SETD2, and the first demonstration of functional mutations separating di-methylating from tri-methylating activity. We propose three complementary aims: 1) to define the chromatin reprogramming and transcriptional effects of SETD2 mutation, revealing critical mechanistic features that link histone modification and nucleosome position to the transcriptional and DNA repair defects associated with SETD2 loss, 2) to utilize the separation of function revealed by high severity SETD2 mutants in the catalytic (SET) domain and the RNA polymerase II interactions domain (SRI) to reveal important determinants of the genomic phenotype, and 3) to explore discrete functions associated with SETD2 loss mediated by the altered H3K36me3 mark, by systematically examining the histone "reader" molecules that transduce signals for DNA methylation, DNA repair, and transcriptional elongation. Taken together, these studies will define the mechanistic link between SETD2 loss of function and cancer development, as well as reveal novel opportunities for biomarker or therapeutic interventions.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ian J Davis其他文献

Linking germline and somatic variation in Ewing sarcoma
尤因肉瘤中种系和体细胞变异的联系
  • DOI:
    10.1038/ng.3387
  • 发表时间:
    2015-08-27
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Nicholas C Gomez;Ian J Davis
  • 通讯作者:
    Ian J Davis

Ian J Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ian J Davis', 18)}}的其他基金

Developmental control of chromatin states in cancer
癌症中染色质状态的发育控制
  • 批准号:
    10567242
  • 财政年份:
    2023
  • 资助金额:
    $ 45.97万
  • 项目类别:
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research
开发空化增强技术以获取存档组织以进行基于表观遗传学的生物医学研究
  • 批准号:
    10211263
  • 财政年份:
    2021
  • 资助金额:
    $ 45.97万
  • 项目类别:
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research
开发空化增强技术以获取存档组织以进行基于表观遗传学的生物医学研究
  • 批准号:
    10580496
  • 财政年份:
    2021
  • 资助金额:
    $ 45.97万
  • 项目类别:
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research
开发空化增强技术以获取存档组织以进行基于表观遗传学的生物医学研究
  • 批准号:
    10381604
  • 财政年份:
    2021
  • 资助金额:
    $ 45.97万
  • 项目类别:
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research
开发空化增强技术以获取存档组织以进行基于表观遗传学的生物医学研究
  • 批准号:
    10576937
  • 财政年份:
    2021
  • 资助金额:
    $ 45.97万
  • 项目类别:
Unified Program for Therapeutics in Children (UPTiC)
儿童治疗统一计划 (UPTiC)
  • 批准号:
    10400848
  • 财政年份:
    2019
  • 资助金额:
    $ 45.97万
  • 项目类别:
Unified Program for Therapeutics in Children (UPTiC)
儿童治疗统一计划 (UPTiC)
  • 批准号:
    10159122
  • 财政年份:
    2019
  • 资助金额:
    $ 45.97万
  • 项目类别:
Unified Program for Therapeutics in Children (UPTiC)
儿童治疗统一计划 (UPTiC)
  • 批准号:
    10676078
  • 财政年份:
    2019
  • 资助金额:
    $ 45.97万
  • 项目类别:
Chromatin maintenance in cancer progression
癌症进展中的染色质维持
  • 批准号:
    9248144
  • 财政年份:
    2015
  • 资助金额:
    $ 45.97万
  • 项目类别:
Chromatin maintenance in cancer progression
癌症进展中的染色质维持
  • 批准号:
    9751217
  • 财政年份:
    2015
  • 资助金额:
    $ 45.97万
  • 项目类别:

相似海外基金

Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
  • 批准号:
    39579-2007
  • 财政年份:
    2011
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
  • 批准号:
    39579-2007
  • 财政年份:
    2010
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Lipolysis: Biochemical Genetics, Physiology and Molecular Circuitry
脂肪分解:生化遗传学、生理学和分子回路
  • 批准号:
    201793
  • 财政年份:
    2010
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Operating Grants
Vaccinia virus biochemical genetics
痘苗病毒生化遗传学
  • 批准号:
    8053536
  • 财政年份:
    2010
  • 资助金额:
    $ 45.97万
  • 项目类别:
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
  • 批准号:
    39579-2007
  • 财政年份:
    2009
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
  • 批准号:
    39579-2007
  • 财政年份:
    2008
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial biphenyl catabolic pathway enzymes
细菌联苯分解代谢途径酶的生化、遗传学和分子生物学
  • 批准号:
    39579-2007
  • 财政年份:
    2007
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
  • 批准号:
    39579-2002
  • 财政年份:
    2006
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
  • 批准号:
    39579-2002
  • 财政年份:
    2005
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
Biochemical, genetics and molecular biology of the bacterial bipehnyl catabolic pathway
细菌联苯分解代谢途径的生化、遗传学和分子生物学
  • 批准号:
    39579-2002
  • 财政年份:
    2004
  • 资助金额:
    $ 45.97万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了